WO2021143181A1 - Method for preparing oxazole compound - Google Patents

Method for preparing oxazole compound Download PDF

Info

Publication number
WO2021143181A1
WO2021143181A1 PCT/CN2020/115924 CN2020115924W WO2021143181A1 WO 2021143181 A1 WO2021143181 A1 WO 2021143181A1 CN 2020115924 W CN2020115924 W CN 2020115924W WO 2021143181 A1 WO2021143181 A1 WO 2021143181A1
Authority
WO
WIPO (PCT)
Prior art keywords
formula
butyl
equivalents
carbon atoms
compound represented
Prior art date
Application number
PCT/CN2020/115924
Other languages
French (fr)
Chinese (zh)
Inventor
周有桂
陈卫勇
赵雷
黄尖
王剑
杨运晗
陈志荣
李浩然
Original Assignee
上虞新和成生物化工有限公司
浙江新和成股份有限公司
山东新和成精化科技有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 上虞新和成生物化工有限公司, 浙江新和成股份有限公司, 山东新和成精化科技有限公司 filed Critical 上虞新和成生物化工有限公司
Publication of WO2021143181A1 publication Critical patent/WO2021143181A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/36One oxygen atom
    • C07D263/42One oxygen atom attached in position 5

Abstract

The present invention relates to a method for preparing an oxazole compound. An additive represented by a formula (I) or (II) or (III) is added into an organic solvent and organic alkali (especially triethylamine), an organic solution of phosgene or diphosgene or triphosgene is dropwise added to perform a cyclization reaction with a compound (IV), and thus a product (V) at a high yield can be obtained and the generation of byproducts can be greatly inhibited. The reaction conditions in the present invention are mild, and compared with a method without addition of additives, the technical solution in the present invention can improve the yield of the product (V) to 95% or more and reduce the byproducts by 10% or more.

Description

一种制备噁唑类化合物的方法A method for preparing oxazole compounds 技术领域Technical field
本发明属于有机合成技术领域,具体涉及一种制备噁唑类化合物的方法。The invention belongs to the technical field of organic synthesis, and specifically relates to a method for preparing oxazole compounds.
背景技术Background technique
噁唑类化合物是一类重要的杂环化合物,一些具有噁唑环的化合物具有生物活性,是重要的医药中间体。例如,4-甲基-5-烷氧基-取代噁唑类化合物可以用于合成维生素B6。Oxazole compounds are an important class of heterocyclic compounds. Some compounds with oxazole rings have biological activity and are important pharmaceutical intermediates. For example, 4-methyl-5-alkoxy-substituted oxazole compounds can be used to synthesize vitamin B6.
US3560516公开了一种利用光气制备噁唑衍生物的方法,该方法包括在有机碱如三乙胺的存在下、在存在或不存在有机溶剂的情况下,使光气与N-草酰化氨基酸酯化合物发生环合反应。该方法可以普遍以50~80%的收率得到噁唑衍生物。收率较低的原因主要是在该反应体系中,光气极易与三乙胺发生副反应而生成大量的N,N-二乙基甲酰氯,从而消耗了大量的光气(Heterocycles,1997,46,101-104;Org.Lett.,2012,14,3676–3679.)。US3560516 discloses a method for preparing oxazole derivatives using phosgene. The method includes phosgene and N-oxalylation in the presence of an organic base such as triethylamine, in the presence or absence of an organic solvent The amino acid ester compound undergoes a cyclization reaction. This method can generally obtain oxazole derivatives with a yield of 50-80%. The main reason for the lower yield is that in the reaction system, phosgene easily reacts with triethylamine to generate a large amount of N,N-diethylformyl chloride, which consumes a large amount of phosgene (Heterocycles, 1997). , 46, 101-104; Org. Lett., 2012, 14, 3676–3679.).
CN102060801A1公开了一种5-烷氧基-取代噁唑类化合物的合成方法,该方法包括,向氨基酸酯衍生物、作为缚酸剂的三乙胺和作为催化剂的在N,N-二乙基苯甲酰胺的苯环上N,N-二乙基甲酰胺基的对位具有卤素或硝基取代基的化合物的有机溶剂溶液中,滴加三光气的有机溶剂溶液进行反应。该方法获得的目标产物的收率只有80%左右。CN102060801A1 discloses a method for synthesizing 5-alkoxy-substituted oxazole compounds. The method includes amino acid ester derivatives, triethylamine as an acid binding agent, and N,N-diethyl as a catalyst. In the organic solvent solution of the compound having halogen or nitro substituent at the para position of the N,N-diethylformamide group on the benzene ring of benzamide, the organic solvent solution of triphosgene is added dropwise to carry out the reaction. The yield of the target product obtained by this method is only about 80%.
CN104447605A1公开了一种4-甲基-5-乙氧基噁唑的工业制备方法,该方法包括,向含有N-乙氧草酰丙氨酸乙酯、三光气和催化剂吡啶或酰氯的氯仿溶液中,滴加三乙胺进行反应。该方法获得的目标产物的收率最高只有80%,而且,该方法使用易挥发的具有潜在致癌性的氯仿作为反应体系的溶剂,而 未提及是否适合采用其它有机溶剂。CN104447605A1 discloses an industrial preparation method of 4-methyl-5-ethoxyoxazole, which comprises adding a chloroform solution containing N-ethoxyoxalanine ethyl ester, triphosgene and a catalyst pyridine or acid chloride During the reaction, triethylamine was added dropwise. The maximum yield of the target product obtained by this method is only 80%, and the method uses volatile and potentially carcinogenic chloroform as the solvent of the reaction system without mentioning whether it is suitable to use other organic solvents.
发明内容Summary of the invention
发明要解决的问题The problem to be solved by the invention
本发明的目的是提供一种制备噁唑类化合物的方法,旨在解决现有技术中光气与底物氨基酸酯衍生物反应制备噁唑类化合物过程中所存在的目标产物收率较低、产生较大量副产品的问题。The purpose of the present invention is to provide a method for preparing oxazole compounds, which aims to solve the problem of low yield of target products in the process of preparing oxazole compounds by reacting phosgene with substrate amino acid ester derivatives in the prior art. The problem of producing a larger amount of by-products.
用于解决问题的方案Solutions used to solve the problem
为了实现上述目的,本发明提供了一种制备噁唑类化合物的方法,所述方法包括,向含有选自下式(I)表示的三烃基氧膦、下式(II)表示的磷酸三烃基酯和下式(III)表示的芳基硼酸化合物中的一种或多种的助剂,下式(IV)表示的草酰化氨基酸酯化合物和有机碱的有机溶剂溶液中,添加选自光气、双光气和三光气中的一种或多种的有机溶剂溶液进行反应,得到式(V)所示的噁唑类化合物:In order to achieve the above object, the present invention provides a method for preparing oxazole compounds, the method comprises: Ester and one or more of the aryl boronic acid compound represented by the following formula (III), the oxalylated amino acid ester compound represented by the following formula (IV) and the organic solvent solution of an organic base are added to an organic solvent solution selected from light One or more of the organic solvent solutions of phosgene, diphosgene and triphosgene are reacted to obtain the oxazole compound represented by formula (V):
Figure PCTCN2020115924-appb-000001
Figure PCTCN2020115924-appb-000001
式(I)中,各R 1相同或不同,并且选自包含1~20个碳原子的烷基、包含3~20个碳原子的环烷基或者包含6~20个碳原子的取代或未取代的芳基;优选甲基、乙基、丙基、正丁基、异丁基、叔丁基、己基、环己基、辛基、正十一烷基、苯基、对甲基苯基、或对甲氧基苯基;更优选苯基、对甲基苯基、叔丁基、或环己基; In formula (I), each R 1 is the same or different, and is selected from an alkyl group containing 1 to 20 carbon atoms, a cycloalkyl group containing 3 to 20 carbon atoms, or substituted or unsubstituted 6 to 20 carbon atoms. Substituted aryl groups; preferably methyl, ethyl, propyl, n-butyl, isobutyl, tert-butyl, hexyl, cyclohexyl, octyl, n-undecyl, phenyl, p-methylphenyl, Or p-methoxyphenyl; more preferably phenyl, p-methylphenyl, tert-butyl, or cyclohexyl;
式(II)中,各R 2相同或不同,并且选自包含1~20个碳原子的烷基、包含3~20个碳原子的环烷基或者包含6~20个碳原子的取代或未取代的芳基,优选甲基、乙基、丙基、正丁基、异丁基、叔丁基、己基、环己基、辛 基、正十一烷基、苯基、对甲基苯基、或对甲氧基苯基;更优选苯基、乙基、或异丙基; In formula (II), each R 2 is the same or different, and is selected from an alkyl group containing 1-20 carbon atoms, a cycloalkyl group containing 3-20 carbon atoms, or substituted or unsubstituted 6-20 carbon atoms. Substituted aryl groups, preferably methyl, ethyl, propyl, n-butyl, isobutyl, tert-butyl, hexyl, cyclohexyl, octyl, n-undecyl, phenyl, p-methylphenyl, Or p-methoxyphenyl; more preferably phenyl, ethyl, or isopropyl;
式(III)中,各R 3相同或不同,并且选自氢、或包含1~10个碳原子的烷基;
Figure PCTCN2020115924-appb-000002
为包含6~20个碳原子的取代或未取代的芳基,优选苯基、对甲基苯基、对氯苯基、对甲氧基苯基、或萘基;
In formula (III), each R 3 is the same or different, and is selected from hydrogen or an alkyl group containing 1 to 10 carbon atoms;
Figure PCTCN2020115924-appb-000002
Is a substituted or unsubstituted aryl group containing 6-20 carbon atoms, preferably phenyl, p-methylphenyl, p-chlorophenyl, p-methoxyphenyl, or naphthyl;
式(IV)和(V)中,各R 4相同或不同,并且选自包含1~5个碳原子的烷基,优选甲基、乙基、正丙基、异丙基、或正丁基;R 5为H或者包含1~5个碳原子的烷基,优选甲基、乙基、正丙基、异丙基、或正丁基。 In formulas (IV) and (V), each R 4 is the same or different, and is selected from alkyl groups containing 1 to 5 carbon atoms, preferably methyl, ethyl, n-propyl, isopropyl, or n-butyl ; R 5 is H or an alkyl group containing 1 to 5 carbon atoms, preferably methyl, ethyl, n-propyl, isopropyl, or n-butyl.
根据本发明提供的制备噁唑类化合物的方法,式(IV)表示的草酰化氨基酸酯化合物的质量与反应体系中的有机溶剂的总体积的比为0.05g/mL~1.0g/mL,优选0.1g/mL~0.5g/mL。According to the method for preparing oxazole compounds provided by the present invention, the ratio of the mass of the oxalylated amino acid ester compound represented by formula (IV) to the total volume of the organic solvent in the reaction system is 0.05 g/mL to 1.0 g/mL, It is preferably 0.1 g/mL to 0.5 g/mL.
根据本发明提供的制备噁唑类化合物的方法,所述助剂的用量为所述式(IV)表示的草酰化氨基酸酯化合物的0.01~0.2当量,优选0.05~0.1当量。According to the method for preparing oxazole compounds provided by the present invention, the amount of the auxiliary agent is 0.01 to 0.2 equivalents, preferably 0.05 to 0.1 equivalents of the oxalylated amino acid ester compound represented by the formula (IV).
根据本发明提供的制备噁唑类化合物的方法,所述有机碱的用量为所述光气用量的0.06~6当量,优选1~6当量;或者为双光气用量的0.12~12当量,优选2~12当量;或者为三光气用量的0.18~18当量,优选3~18当量。According to the method for preparing oxazole compounds provided by the present invention, the amount of the organic base is 0.06-6 equivalents of the amount of phosgene, preferably 1-6 equivalents; or 0.12-12 equivalents of the amount of diphosgene, preferably 2-12 equivalents; or 0.18-18 equivalents of the amount of triphosgene, preferably 3-18 equivalents.
根据本发明提供的制备噁唑类化合物的方法,所述光气的用量为所述式(IV)表示的草酰化氨基酸酯化合物的1~3当量,优选1~2当量;所述双光气的用量为所述式(IV)表示的草酰化氨基酸酯化合物的0.5~1.5当量,优选0.5~1当量;所述三光气的用量为所述式(IV)表示的草酰化氨基酸酯化合物的0.33~1当量,优选0.33~0.7当量。According to the method for preparing oxazole compounds provided by the present invention, the amount of phosgene is 1 to 3 equivalents, preferably 1 to 2 equivalents, of the oxalylated amino acid ester compound represented by formula (IV); The amount of gas used is 0.5 to 1.5 equivalents, preferably 0.5 to 1 equivalent, of the oxalylated amino acid ester compound represented by the formula (IV); the amount of triphosgene is the oxalylated amino acid ester represented by the formula (IV) 0.33 to 1 equivalent of the compound, preferably 0.33 to 0.7 equivalent.
根据本发明提供的制备噁唑类化合物的方法,所述反应温度是-10℃~180℃,优选25℃~100℃。According to the method for preparing oxazole compounds provided by the present invention, the reaction temperature is -10°C to 180°C, preferably 25°C to 100°C.
根据本发明提供的制备噁唑类化合物的方法,所述式(I)表示的三烃 基氧膦为三苯基氧膦、三对甲基苯基氧膦、三叔丁基氧膦、和三环己基氧膦中的一种或多种;According to the method for preparing oxazole compounds provided by the present invention, the trihydrocarbyl phosphine oxide represented by the formula (I) is triphenyl phosphine oxide, tri-p-methylphenyl phosphine oxide, tri-tert-butyl phosphine oxide, and tri-tert-butyl phosphine oxide. One or more of cyclohexyl phosphine oxide;
所述式(II)表示的磷酸三烃基酯为磷酸三苯酯、磷酸三乙酯、和磷酸三异丙酯中的一种或多种;The trihydrocarbyl phosphate represented by formula (II) is one or more of triphenyl phosphate, triethyl phosphate, and triisopropyl phosphate;
所述式(III)表示的芳基硼酸化合物为苯硼酸、萘硼酸、对甲氧基苯硼酸、和对甲基苯硼酸中的一种或多种。The arylboronic acid compound represented by the formula (III) is one or more of phenylboronic acid, naphthaleneboronic acid, p-methoxyphenylboronic acid, and p-tolueneboronic acid.
根据本发明提供的制备噁唑类化合物的方法,所述式(IV)表示的草酰化氨基酸酯化合物为N-乙氧草酰丙氨酸乙酯、N-正丁氧草酰丙氨酸正丁酯、和N-甲氧草酰丙氨酸甲酯中的一种或多种。According to the method for preparing oxazole compounds provided by the present invention, the oxalylated amino acid ester compound represented by the formula (IV) is N-ethoxy oxalyl alanine ethyl ester and N-butoxy oxalyl alanine One or more of n-butyl ester and N-methoxyoxalanine methyl ester.
根据本发明提供的制备噁唑类化合物的方法,所述有机碱为吡啶、二异丙基乙基胺、二甲胺、三乙胺、4-N,N-二甲氨基吡啶、和4-甲基咪唑中的一种或多种,优选三乙胺。According to the method for preparing oxazole compounds provided by the present invention, the organic base is pyridine, diisopropylethylamine, dimethylamine, triethylamine, 4-N,N-dimethylaminopyridine, and 4- One or more of methylimidazole, preferably triethylamine.
根据本发明提供的制备噁唑类化合物的方法,所述有机溶剂为二氯甲烷、三氯甲烷、1,2-二氯乙烷、1,1,2-三氯乙烷、氯苯、甲苯、二甲苯、N,N-二甲基甲酰胺、甲基叔丁基醚、异丙醚、环戊基甲基醚、乙二醇二甲醚、四氢呋喃、2-甲基四氢呋喃、环己烷、正己烷、和石油醚中的一种或多种;优选二氯甲烷、三氯甲烷、1,1,2-三氯乙烷、氯苯、甲苯、二甲苯、N,N-二甲基甲酰胺、环己烷、正己烷、和石油醚中的一种或多种。According to the method for preparing oxazole compounds provided by the present invention, the organic solvent is dichloromethane, chloroform, 1,2-dichloroethane, 1,1,2-trichloroethane, chlorobenzene, toluene , Xylene, N,N-dimethylformamide, methyl tert-butyl ether, isopropyl ether, cyclopentyl methyl ether, ethylene glycol dimethyl ether, tetrahydrofuran, 2-methyltetrahydrofuran, cyclohexane One or more of, n-hexane, and petroleum ether; preferably dichloromethane, chloroform, 1,1,2-trichloroethane, chlorobenzene, toluene, xylene, N,N-dimethyl One or more of formamide, cyclohexane, n-hexane, and petroleum ether.
发明的效果The effect of the invention
根据本发明提供的制备噁唑类化合物的方法,不仅反应条件温和,反应时间短,反应效率高,可以以95%以上的高收率得到噁唑产物(V),同时可以大大抑制副产品N,N-二乙基甲酰氯的生成。According to the method for preparing oxazole compounds provided by the present invention, the reaction conditions are mild, the reaction time is short, and the reaction efficiency is high. The oxazole product (V) can be obtained at a high yield of more than 95%, and the by-product N, The formation of N-diethylformyl chloride.
具体实施方式Detailed ways
本文所使用的术语“三烃基氧膦”是指具有以下式(I)所示结构式的 化合物,The term "trihydrocarbyl phosphine oxide" as used herein refers to a compound having the structural formula shown in the following formula (I),
Figure PCTCN2020115924-appb-000003
Figure PCTCN2020115924-appb-000003
其中,各R 1相同或不同,并且选自包含1~20个碳原子的烷基、包含3~20个碳原子的环烷基或者包含6~20个碳原子的取代或未取代的芳基,如甲基、乙基、丙基、正丁基、异丁基、叔丁基、己基、环己基、辛基、正十一烷基、苯基、对甲基苯基、或对甲氧基苯基;优选苯基、对甲基苯基、叔丁基、或环己基。 Wherein, each R 1 is the same or different, and is selected from an alkyl group containing 1 to 20 carbon atoms, a cycloalkyl group containing 3 to 20 carbon atoms, or a substituted or unsubstituted aryl group containing 6 to 20 carbon atoms , Such as methyl, ethyl, propyl, n-butyl, isobutyl, tert-butyl, hexyl, cyclohexyl, octyl, n-undecyl, phenyl, p-methylphenyl, or p-methoxy Phenyl; preferably phenyl, p-methylphenyl, t-butyl, or cyclohexyl.
本文所使用的术语“磷酸三烃基酯”是指具有以下式(II)所示结构式的化合物,The term "trihydrocarbyl phosphate" as used herein refers to a compound having the structural formula shown in the following formula (II),
Figure PCTCN2020115924-appb-000004
Figure PCTCN2020115924-appb-000004
其中,各R 2相同或不同,并且选自包含1~20个碳原子的烷基、包含3~20个碳原子的环烷基或者包含6~20个碳原子的取代或未取代的芳基,如甲基、乙基、丙基、正丁基、异丁基、叔丁基、己基、环己基、辛基、正十一烷基、苯基、对甲基苯基、或对甲氧基苯基;优选苯基、乙基、或异丙基。 Wherein, each R 2 is the same or different, and is selected from an alkyl group containing 1 to 20 carbon atoms, a cycloalkyl group containing 3 to 20 carbon atoms, or a substituted or unsubstituted aryl group containing 6 to 20 carbon atoms , Such as methyl, ethyl, propyl, n-butyl, isobutyl, tert-butyl, hexyl, cyclohexyl, octyl, n-undecyl, phenyl, p-methylphenyl, or p-methoxy Phenyl; preferably phenyl, ethyl, or isopropyl.
本文所使用的术语“芳基硼酸化合物”是指具有以下式(III)所示结构式的化合物,The term "aryl boronic acid compound" as used herein refers to a compound having the structural formula shown in the following formula (III),
Figure PCTCN2020115924-appb-000005
Figure PCTCN2020115924-appb-000005
其中,各R 3相同或不同,并且选自氢、或包含1~10个碳原子的烷基;
Figure PCTCN2020115924-appb-000006
为包含6~20个碳原子的取代或未取代的芳基,如苯基、对甲基苯基、对氯苯基、对甲氧基苯基、或萘基。
Wherein, each R 3 is the same or different, and is selected from hydrogen or an alkyl group containing 1 to 10 carbon atoms;
Figure PCTCN2020115924-appb-000006
It is a substituted or unsubstituted aryl group containing 6-20 carbon atoms, such as phenyl, p-methylphenyl, p-chlorophenyl, p-methoxyphenyl, or naphthyl.
本文所使用的术语“草酰化氨基酸酯化合物”是指具有以下式(IV)所示结构式的化合物,The term "oxalylated amino acid ester compound" as used herein refers to a compound having the structural formula shown in the following formula (IV),
Figure PCTCN2020115924-appb-000007
Figure PCTCN2020115924-appb-000007
其中,各R 4相同或不同,并且选自包含1~5个碳原子的烷基,如甲基、乙基、正丙基、异丙基、或正丁基;R 5为H或者包含1~5个碳原子的烷基,如甲基、乙基、正丙基、异丙基、或正丁基。 Wherein, each R 4 is the same or different, and is selected from alkyl groups containing 1 to 5 carbon atoms, such as methyl, ethyl, n-propyl, isopropyl, or n-butyl; R 5 is H or contains 1 Alkyl groups of ~5 carbon atoms, such as methyl, ethyl, n-propyl, isopropyl, or n-butyl.
本文所使用的术语“噁唑类化合物”是指具有以下式(V)所示结构式的化合物,The term "oxazole compound" as used herein refers to a compound having the structural formula shown in the following formula (V),
Figure PCTCN2020115924-appb-000008
Figure PCTCN2020115924-appb-000008
其中,R 4和R 5与以上式(IV)中的R 4和R 5具有相同的含义。 Wherein, R 4 and R 5 R in the above formula (IV) 4 and R 5 have the same meaning.
根据本发明提供的制备噁唑类化合物的方法,其具有以下反应式:According to the method for preparing oxazole compounds provided by the present invention, it has the following reaction formula:
Figure PCTCN2020115924-appb-000009
Figure PCTCN2020115924-appb-000009
本发明的发明人根据实验结果证明,在使用光气或双光气或三光气制备噁唑类化合物时,添加特定结构的含磷或含硼化合物,会促进主反应的高效进行,而对副反应有抑制作用。发明人通过实验研究发现,根据本发明提供的制备噁唑类化合物的方法,可以高收率得到目标产物式(V)表示的噁唑类化合物,同时可以大大抑制副产品的生成。The inventors of the present invention have proved based on experimental results that when phosgene, diphosgene or triphosgene is used to prepare oxazole compounds, the addition of phosphorus-containing or boron-containing compounds with a specific structure will promote the efficient progress of the main reaction and prevent the side effects. The reaction has an inhibitory effect. The inventor found through experimental research that according to the method for preparing oxazole compounds provided by the present invention, the target product oxazole compound represented by formula (V) can be obtained in a high yield, and the generation of by-products can be greatly suppressed at the same time.
根据本发明提供的制备噁唑类化合物的方法,采用选自式(I)表示的三烃基氧膦、式(II)表示的磷酸三烃基酯和式(III)表示的芳基硼酸化合物中的至少一种作为助剂。其中,式(I)表示的三烃基氧膦优选为三苯基氧膦、三对甲基苯基氧膦、三叔丁基氧膦、和三环己基氧膦中的一种或多种;式(II)表示的磷酸三烃基酯优选为磷酸三苯酯、磷酸三乙酯、和磷酸三异丙酯中的一种或多种;式(III)表示的芳基硼酸化合物优选为苯硼酸、萘硼酸、对甲氧基苯硼酸、和对甲基苯硼酸中的一种或多种。According to the method for preparing oxazole compounds provided by the present invention, one selected from the group consisting of trihydrocarbyl phosphine oxide represented by formula (I), trihydrocarbyl phosphate represented by formula (II), and aryl boronic acid compound represented by formula (III) At least one is used as an adjuvant. Among them, the trihydrocarbyl phosphine oxide represented by formula (I) is preferably one or more of triphenyl phosphine oxide, tri-p-methylphenyl phosphine oxide, tri-tert-butyl phosphine oxide, and tricyclohexyl phosphine oxide; The trihydrocarbyl phosphate represented by formula (II) is preferably one or more of triphenyl phosphate, triethyl phosphate, and triisopropyl phosphate; the aryl boronic acid compound represented by formula (III) is preferably phenylboronic acid One or more of, naphthalene boronic acid, p-methoxyphenyl boronic acid, and p-toluene boronic acid.
根据本发明提供的制备噁唑类化合物的方法,所采用的反应底物是由式(IV)表示的草酰化氨基酸酯化合物,其优选为N-乙氧草酰丙氨酸乙酯、N-正丁氧草酰丙氨酸正丁酯、和N-甲氧草酰丙氨酸甲酯中的一种或多种。According to the method for preparing oxazole compounds provided by the present invention, the reaction substrate used is an oxalylated amino acid ester compound represented by formula (IV), which is preferably N-ethoxyoxalanine ethyl ester, N -One or more of n-butoxy oxalyl alanine n-butyl ester and N-methoxy oxalyl alanine methyl ester.
根据本发明提供的制备噁唑类化合物的方法,反应体系的反应温度优选为-10℃~180℃,更优选25℃~100℃。According to the method for preparing oxazole compounds provided by the present invention, the reaction temperature of the reaction system is preferably -10°C to 180°C, more preferably 25°C to 100°C.
根据本发明提供的制备噁唑类化合物的方法,所述式(IV)表示的草酰化氨基酸酯化合物的质量与反应体系中的有机溶剂的总体积的比为0.05g/mL~1.0g/mL,优选0.1g/mL~0.5g/mL,高于1.0g/mL时,反应析出较多有机胺盐酸盐,传质效果变差,不利于提高转化率和选择性;低于0.05g/mL,体系浓度过低,会降低反应转化率。According to the method for preparing oxazole compounds provided by the present invention, the ratio of the mass of the oxalylated amino acid ester compound represented by the formula (IV) to the total volume of the organic solvent in the reaction system is 0.05g/mL~1.0g/ mL, preferably 0.1g/mL~0.5g/mL, when it is higher than 1.0g/mL, more organic amine hydrochloride will be precipitated in the reaction, and the mass transfer effect will be worse, which is not conducive to improving the conversion rate and selectivity; less than 0.05g /mL, if the system concentration is too low, the reaction conversion rate will be reduced.
所述助剂的用量为所述式(IV)表示的草酰化氨基酸酯化合物的0.01~0.2当量,优选0.05~0.1当量,助剂用量小于0.01当量,对副反应抑制效果变差,助剂用量大于0.2当量,会对后续提纯及反应造成不利影响。The amount of the auxiliary agent is 0.01 to 0.2 equivalents, preferably 0.05 to 0.1 equivalents, of the oxalylated amino acid ester compound represented by the formula (IV). The amount of the auxiliary agent is less than 0.01 equivalent, and the side reaction inhibitory effect becomes poor. If the amount is greater than 0.2 equivalent, it will adversely affect the subsequent purification and reaction.
所述有机碱的用量为所述光气用量的0.06~6当量,优选1~6当量;或者为双光气用量的0.12~12当量,优选2~12当量;或者为三光气用量的0.18~18当量,优选3~18当量,有机碱与光气、双光气、三光气的当量在上述范围内时,反应转化率,选择性高;有机碱与光气、双光气、三光气的当量低于上述范围的下限时,原料转化不完全,有机碱与光气、双光气、三光气的当量高于上述范围的上限时,有机碱会与光气、双光气、三光气反应,生成较多对应酰氯,造成原料浪费。The amount of the organic base is 0.06 to 6 equivalents of the amount of phosgene, preferably 1 to 6 equivalents; or 0.12 to 12 equivalents of the amount of diphosgene, preferably 2 to 12 equivalents; or 0.18 to the amount of triphosgene 18 equivalents, preferably 3-18 equivalents. When the equivalents of organic base and phosgene, diphosgene, and triphosgene are within the above range, the reaction conversion rate and selectivity are high; the ratio of organic base to phosgene, diphosgene, and triphosgene When the amount is lower than the lower limit of the above range, the conversion of raw materials is not complete. When the equivalent of organic base and phosgene, diphosgene, and triphosgene is higher than the upper limit of the above range, the organic base will react with phosgene, diphosgene, and triphosgene. , Generate more corresponding acid chlorides, resulting in waste of raw materials.
所述光气的用量为所述式(IV)表示的草酰化氨基酸酯化合物的用量的1~3当量,优选1~2当量;所述双光气的用量为所述式(IV)表示的草酰化氨基酸酯化合物的0.5~1.5当量,优选0.5~1当量;所述三光气的用量为所述式(IV)表示的草酰化氨基酸酯化合物的0.33~1当量,优选0.33~0.7当量。光气、双光气或三光气与式(IV)表示的草酰化氨基酸酯化合物的当量低于上述范围的下限时,草酰化氨基酸酯化合物剩余较多;光气、双光气或三光气与式(IV)表示的草酰化氨基酸酯化合物的当量高于上述范围的上限时,生成较多酰氯,并降低反应选择性,助剂起不到有效的抑制作用。The dosage of the phosgene is 1 to 3 equivalents, preferably 1 to 2 equivalents, of the dosage of the oxalylated amino acid ester compound represented by the formula (IV); the dosage of the diphosgene is represented by the formula (IV) 0.5 to 1.5 equivalents of the oxalylated amino acid ester compound, preferably 0.5 to 1 equivalent; the amount of triphosgene is 0.33 to 1 equivalent of the oxalylated amino acid ester compound represented by the formula (IV), preferably 0.33 to 0.7 equivalent. When the equivalent weight of phosgene, diphosgene or triphosgene to the oxalylated amino acid ester compound represented by formula (IV) is lower than the lower limit of the above range, more oxalylated amino acid ester compound remains; phosgene, diphosgene or triphosgene When the equivalent of gas and the oxalylated amino acid ester compound represented by formula (IV) is higher than the upper limit of the above range, more acid chlorides are generated, and reaction selectivity is reduced, and the auxiliary agent does not have an effective inhibitory effect.
根据本发明提供的制备噁唑类化合物的方法,所采用的有机溶剂为可溶解本发明的反应物和助剂,并且对本发明的反应物和助剂为惰性的有机溶剂。在优选情况下,所述有机溶剂的实例包括二氯甲烷、三氯甲烷、1,2-二氯乙烷、1,1,2-三氯乙烷、氯苯、甲苯、二甲苯、N,N-二甲基甲酰胺、甲基叔丁基醚、异丙醚、环戊基甲基醚、乙二醇二甲醚、四氢呋喃、2-甲基四氢呋喃、环己烷、正己烷、和石油醚中的一种或多种;特别地,更优选二氯甲烷、三氯甲烷、1,1,2-三氯乙烷、氯苯、甲苯、二甲苯、N,N-二甲基甲酰胺、环己烷、正己烷、和石油醚中的一种或多种。According to the method for preparing oxazole compounds provided by the present invention, the organic solvent used is an organic solvent that can dissolve the reactants and assistants of the present invention, and is inert to the reactants and assistants of the present invention. In a preferred case, examples of the organic solvent include dichloromethane, chloroform, 1,2-dichloroethane, 1,1,2-trichloroethane, chlorobenzene, toluene, xylene, N, N-dimethylformamide, methyl tert-butyl ether, isopropyl ether, cyclopentyl methyl ether, ethylene glycol dimethyl ether, tetrahydrofuran, 2-methyltetrahydrofuran, cyclohexane, n-hexane, and petroleum One or more of ethers; in particular, dichloromethane, chloroform, 1,1,2-trichloroethane, chlorobenzene, toluene, xylene, N,N-dimethylformamide are more preferred One or more of, cyclohexane, n-hexane, and petroleum ether.
根据本发明提供的制备噁唑类化合物的方法,在优选情况下,所采用的有机碱为吡啶、二异丙基乙基胺、二甲胺、三乙胺、4-N,N-二甲氨基吡啶、 和4-甲基咪唑中的一种或多种;特别地优选三乙胺。According to the method for preparing oxazole compounds provided by the present invention, in a preferred case, the organic base used is pyridine, diisopropylethylamine, dimethylamine, triethylamine, 4-N,N-dimethylamine One or more of aminopyridine, and 4-methylimidazole; particularly preferred is triethylamine.
根据本发明提供的制备噁唑类化合物的方法,其优选的实施方式为:将反应底物式(IV)所示的草酰化氨基酸酯化合物、以上所述的助剂和有机碱溶解在有机溶剂中,在滴加温度和搅拌下滴加光气、双光气或三光气的有机溶剂溶液0.5-3小时,然后在反应温度下加热搅拌1-3小时,直至检测到反应底物完全消耗。According to the method for preparing oxazole compounds provided by the present invention, the preferred embodiment is: dissolving the oxalylated amino acid ester compound represented by formula (IV), the above-mentioned auxiliary agent and organic base in the organic In the solvent, the organic solvent solution of phosgene, diphosgene or triphosgene is added dropwise under stirring temperature and stirring for 0.5-3 hours, and then heated and stirred at the reaction temperature for 1-3 hours, until the complete consumption of the reaction substrate is detected .
在上述优选的实施方式中,所述滴加温度优选为-5℃~10℃、更优选0℃~5℃,所述滴加后的反应温度更优选为25℃~80℃。In the above preferred embodiment, the dropping temperature is preferably -5°C to 10°C, more preferably 0°C to 5°C, and the reaction temperature after the dropping is more preferably 25°C to 80°C.
根据本发明提供的制备噁唑类化合物的方法,在反应体系的反应结束后,通过气相色谱检测反应产物收率及副产品的生成情况。According to the method for preparing oxazole compounds provided by the present invention, after the reaction of the reaction system is completed, the yield of the reaction product and the formation of by-products are detected by gas chromatography.
以下结合非限制性的实施例对本发明进行详细说明。The present invention will be described in detail below in conjunction with non-limiting examples.
实施例Example
4-甲基-5-乙氧基噁唑的制备Preparation of 4-methyl-5-ethoxyoxazole
实施例1Example 1
(使用苯硼酸为助剂):(Use phenylboronic acid as auxiliary):
在反应瓶中,加入24g N-乙氧草酰丙氨酸乙酯(0.11mol),0.13g苯硼酸(1.1mmol)和42.4g三乙胺(0.42mol),用45mL三氯甲烷溶解后,0~5℃及搅拌条件下滴加三光气溶液(13.1g,0.044mol,溶解于50mL三氯甲烷),约1小时滴加完毕,然后再加热到50℃反应1小时,气相色谱跟踪反应发现原料N-乙氧草酰丙氨酸乙酯完全消耗。反应结束后,通过气相色谱检测,确认所得产品为4-甲基-5-乙氧基噁唑,且其内标摩尔收率为96%(收率基于N-乙氧草酰丙氨酸乙酯,内标法检测,正十八烷为内标),同时仅生成3%(摩尔收率)的N,N-二乙基甲酰氯(收率基于3倍的三光气,外标法检测)。In the reaction flask, add 24g N-ethoxyoxalanine ethyl ester (0.11mol), 0.13g phenylboronic acid (1.1mmol) and 42.4g triethylamine (0.42mol). After dissolving with 45mL chloroform, Add triphosgene solution (13.1g, 0.044mol, dissolved in 50mL chloroform) dropwise at 0~5℃ and stirring condition, add dropwise in about 1 hour, then heat to 50℃ and react for 1 hour. Gas chromatographic tracking reaction found The raw material N-ethoxyoxalanine ethyl ester is completely consumed. After the reaction, it was confirmed by gas chromatography that the product obtained was 4-methyl-5-ethoxyoxazole, and its internal standard molar yield was 96% (yield based on N-ethoxyoxalanine ethyl) Ester, internal standard method detection, n-octadecane as internal standard), while only generating 3% (molar yield) of N,N-diethylformyl chloride (yield based on 3 times triphosgene, external standard method detection ).
比较例1 Comparative example 1 :
在反应瓶中,加入24g N-乙氧草酰丙氨酸乙酯(0.11mol)和42.4g三乙 胺(0.42mol),用45mL三氯甲烷溶解后,0~5℃及搅拌条件下滴加三光气溶液(13.1g,0.044mol,溶解于50mL三氯甲烷),约1小时滴加完毕,然后升温至25~30℃反应2小时;然后再加热到50℃反应3小时,气相色谱跟踪反应发现原料N-乙氧草酰丙氨酸乙酯完全消耗。反应结束后,通过气相色谱检测,确认所得产品为4-甲基-5-乙氧基噁唑,且其内标摩尔收率为86%(收率基于N-乙氧草酰丙氨酸乙酯,内标法检测,正十八烷为内标),同时生成13%(摩尔收率)的N,N-二乙基甲酰氯(收率基于3倍的三光气,外标法检测)。In the reaction flask, add 24g of N-ethoxyoxalanine ethyl ester (0.11mol) and 42.4g of triethylamine (0.42mol), dissolve with 45mL of chloroform, and drop at 0~5℃ under stirring conditions. Add triphosgene solution (13.1g, 0.044mol, dissolved in 50mL chloroform), add dropwise in about 1 hour, then increase the temperature to 25~30℃ and react for 2 hours; then heat to 50℃ and react for 3 hours, followed by gas chromatography The reaction found that the raw material N-ethoxyoxalanine ethyl ester was completely consumed. After the reaction, it was confirmed by gas chromatography to confirm that the product obtained was 4-methyl-5-ethoxyoxazole, and its internal standard molar yield was 86% (yield based on N-ethoxyoxalanine ethyl) Ester, detected by internal standard method, n-octadecane is internal standard), and 13% (molar yield) of N,N-diethylformyl chloride is generated at the same time (yield is based on 3 times triphosgene, detected by external standard method) .
4-甲基-5-正丁氧基噁唑的制备Preparation of 4-methyl-5-n-butoxyoxazole
实施例2-1Example 2-1
(使用磷酸三乙酯为助剂):(Use triethyl phosphate as auxiliary):
在反应瓶中,加入30g N-正丁氧草酰丙氨酸正丁酯(0.11mol),0.9g亚磷酸三乙酯(5.5mmol)和42.4g三乙胺(0.42mol),用45mL三氯甲烷溶解后,0~5℃及搅拌条件下滴加三光气溶液(13.1g,0.044mol,溶解于50mL三氯甲烷),约1小时滴加完毕,然后再加热到50℃反应1小时,气相色谱跟踪反应发现原料N-正丁氧草酰丙氨酸正丁酯完全消耗。反应结束后,通过气相色谱检测,确认所得产品为4-甲基-5-正丁氧基噁唑,且其内标摩尔收率为95%(收率基于N-正丁氧草酰丙氨酸正丁酯,内标法检测,正十八烷为内标),同时仅生成4%(摩尔收率)的N,N-二乙基甲酰氯(收率基于3倍的三光气,外标法)。In the reaction flask, add 30g N-butoxy oxalylalanine n-butyl ester (0.11mol), 0.9g triethyl phosphite (5.5mmol) and 42.4g triethylamine (0.42mol), and use 45mL triethylamine (0.42mol). After the chloromethane is dissolved, add triphosgene solution (13.1g, 0.044mol, dissolved in 50mL chloroform) dropwise at 0~5°C and stirring. The addition is completed in about 1 hour, and then the reaction is heated to 50°C for 1 hour. Gas chromatography followed the reaction and found that the raw material N-butoxy oxalylalanine n-butyl ester was completely consumed. After the reaction, it was confirmed by gas chromatography that the product obtained was 4-methyl-5-n-butoxyoxazole, and its internal standard molar yield was 95% (yield based on N-butoxyoxalanine N-Butyl acid, detected by internal standard method, n-octadecane is the internal standard), and only 4% (molar yield) of N,N-diethylformyl chloride is generated (yield is based on 3 times of triphosgene, external Standard).
比较例2 Comparative example 2 :
在反应瓶中,加入30g N-正丁氧草酰丙氨酸正丁酯(0.11mol)和42.4g三乙胺(0.42mol),用45mL三氯甲烷溶解后,0~5℃及搅拌条件下滴加三光气溶液(13.1g,0.044mol,溶解于50mL三氯甲烷),约1小时滴加完毕,然后再加热到50℃反应3小时,气相色谱跟踪反应发现原料N-正丁氧草酰 丙氨酸正丁酯消耗完全。反应结束后,通过气相色谱检测,确认所得产品为4-甲基-5-正丁氧基噁唑,且其内标摩尔收率为85%(收率基于N-正丁氧草酰丙氨酸正丁酯,内标法检测,正十八烷为内标),同时生成14%(摩尔收率)的N,N-二乙基甲酰氯(收率基于3倍的三光气,外标法)。In the reaction flask, add 30g N-butoxy oxalylalanine n-butyl ester (0.11mol) and 42.4g triethylamine (0.42mol), dissolve with 45mL chloroform, 0~5℃ and stirring conditions The triphosgene solution (13.1g, 0.044mol, dissolved in 50mL chloroform) was added dropwise to the bottom, and the addition was completed in about 1 hour, and then heated to 50°C for 3 hours. The reaction was followed by gas chromatography and found that the raw material N-butoxy grass The n-butyl acylalanine is completely consumed. After the reaction, it was confirmed by gas chromatography that the product obtained was 4-methyl-5-n-butoxyoxazole, and its internal standard molar yield was 85% (yield based on N-butoxy oxalanine N-Butyl acid, detected by internal standard method, n-octadecane is internal standard), and 14% (molar yield) of N,N-diethylformyl chloride is generated at the same time (yield is based on 3 times triphosgene, external standard) Law).
实施例2-2Example 2-2
(使用三苯基氧膦为助剂)(Use triphenyl phosphine oxide as an additive)
在反应瓶中,加入30g N-正丁氧草酰丙氨酸正丁酯(0.11mol),0.31g三苯基氧膦(1.1mmol),21.2g三乙胺(0.21mol),用45mL三氯甲烷溶解后,0~5℃及搅拌条件下滴加光气溶液(13.1g,0.132mol,溶解于50mL三氯甲烷),约1小时滴加完毕,然后再加热到50℃反应1小时,气相色谱跟踪反应发现原料N-正丁氧草酰丙氨酸正丁酯完全消耗。反应结束后,通过气相色谱检测,确认所得产品为4-甲基-5-正丁氧基噁唑,且其内标摩尔收率为97%(收率基于N-正丁氧草酰丙氨酸正丁酯,内标法检测,正十八烷为内标),同时仅生成3%(摩尔收率)的N,N-二乙基甲酰氯(收率基于光气,外标法)。In the reaction flask, add 30g of N-butoxy oxalylalanine n-butyl ester (0.11mol), 0.31g of triphenylphosphine oxide (1.1mmol), 21.2g of triethylamine (0.21mol), and use 45mL of triethylamine. After the chloromethane is dissolved, add dropwise phosgene solution (13.1g, 0.132mol, dissolved in 50mL chloroform) at 0~5°C and stirring. The addition is completed in about 1 hour, and then the reaction is heated to 50°C for 1 hour. Gas chromatography followed the reaction and found that the raw material N-butoxy oxalylalanine n-butyl ester was completely consumed. After the reaction, it was confirmed by gas chromatography that the product obtained was 4-methyl-5-n-butoxyoxazole, and its internal standard molar yield was 97% (yield based on N-butoxy oxalanine N-Butyl acid, internal standard method detection, n-octadecane as internal standard), while only generating 3% (molar yield) of N,N-diethylformyl chloride (yield based on phosgene, external standard method) .
实施例2-3Example 2-3
(使用三叔丁基氧膦为助剂)(Use tri-tert-butyl phosphine oxide as auxiliary)
在反应瓶中,加入30g N-正丁氧草酰丙氨酸正丁酯(0.11mol),0.48g三叔丁基氧膦(2.2mmol),21.2g三乙胺(0.21mol),用45mL三氯甲烷溶解后,0~5℃及搅拌条件下滴加光气溶液(13.1g,0.132mol,溶解于50mL三氯甲烷),约1小时滴加完毕,然后再加热到50℃反应1小时,气相色谱跟踪反应发现原料N-正丁氧草酰丙氨酸正丁酯完全消耗。反应结束后,通过气相色谱检测,确认所得产品为4-甲基-5-正丁氧基噁唑,且其内标摩尔收率为96%(收率基于N-正丁氧草酰丙氨酸正丁酯,内标法检测,正十八烷为内标),同时仅生成2%(摩尔收率)的N,N-二乙基甲酰氯(收率基于光气,外标法)。In the reaction flask, add 30g N-Butoxy oxalylalanine n-butyl ester (0.11mol), 0.48g tri-tert-butyl phosphine oxide (2.2mmol), 21.2g triethylamine (0.21mol), use 45mL After the chloroform is dissolved, add phosgene solution (13.1g, 0.132mol, dissolved in 50mL chloroform) dropwise at 0~5℃ and stirring, and the addition is completed in about 1 hour, and then heat to 50℃ for 1 hour , Gas chromatography followed the reaction and found that the raw material N-butoxy oxalyl alanine n-butyl ester was completely consumed. After the reaction, it was confirmed by gas chromatography that the product obtained was 4-methyl-5-n-butoxyoxazole, and its internal standard molar yield was 96% (yield based on N-butoxy oxalylalanine) N-Butyl acid, detected by internal standard method, n-octadecane is internal standard), and only 2% (molar yield) of N,N-diethylformyl chloride is generated (yield based on phosgene, external standard method) .
4-甲基-5-甲氧基噁唑的制备Preparation of 4-methyl-5-methoxyoxazole
实施例3Example 3
(使用三苯基氧膦为助剂)(Use triphenyl phosphine oxide as an additive)
在反应瓶中,加入20.8g N-甲氧草酰丙氨酸甲酯(0.11mol)和42.4g三乙胺(0.42mol),0.31g三苯基氧膦(1.1mmol),用30mL氯苯溶解后,0~5℃及搅拌条件下滴加光气溶液(13.1g,0.132mol,溶解于50mL氯苯),约1小时滴加完毕,然后再加热到50℃反应1.5小时,气相色谱跟踪反应发现原料N-甲氧草酰丙氨酸甲酯完全消耗。反应结束后,通过气相色谱检测,确认所得产品为4-甲基-5-甲氧基噁唑,且其内标摩尔收率为96%(收率基于N-甲氧草酰丙氨酸甲酯,内标法检测,正十八烷为内标),同时生成2%(摩尔收率)的N,N-二乙基甲酰氯(收率基于光气,外标法)。In the reaction flask, add 20.8g N-methoxyoxalanine methyl ester (0.11mol) and 42.4g triethylamine (0.42mol), 0.31g triphenylphosphine oxide (1.1mmol), and use 30mL chlorobenzene After dissolving, add dropwise phosgene solution (13.1g, 0.132mol, dissolved in 50mL chlorobenzene) at 0~5℃ and stirring condition, and the dripping is completed in about 1 hour, and then heated to 50℃ for 1.5 hours for reaction, followed by gas chromatography The reaction found that the raw material N-methoxyoxalanine methyl ester was completely consumed. After the reaction, it was confirmed by gas chromatography that the product obtained was 4-methyl-5-methoxyoxazole, and its internal standard molar yield was 96% (yield based on N-methoxyoxalanine methyl Ester, detected by internal standard method, n-octadecane as internal standard), while generating 2% (molar yield) of N,N-diethylformyl chloride (yield based on phosgene, external standard method).
比较例3Comparative example 3
在反应瓶中,加入20.8g N-甲氧草酰丙氨酸甲酯(0.11mol)和42.4g三乙胺(0.42mol),用30mL氯苯溶解后,0~5℃及搅拌条件下滴加光气溶液(13.1g,0.132mol,溶解于50mL氯苯),约1小时滴加完毕,然后再加热到50℃反应2.5小时,气相色谱跟踪反应发现原料N-甲氧草酰丙氨酸甲酯完全消耗。反应结束后,通过气相色谱检测,确认所得产品为4-甲基-5-甲氧基噁唑,且其内标摩尔收率为86%(收率基于N-甲氧草酰丙氨酸甲酯,内标法检测,正十八烷为内标),同时生成13%(摩尔收率)的N,N-二乙基甲酰氯(收率基于光气,外标法)。In the reaction flask, add 20.8g N-methoxyoxalanine methyl ester (0.11mol) and 42.4g triethylamine (0.42mol), dissolve with 30mL chlorobenzene, and drop at 0~5℃ under stirring conditions. Add phosgene solution (13.1g, 0.132mol, dissolved in 50mL chlorobenzene), add dropwise in about 1 hour, and then heat to 50°C for 2.5 hours. The reaction was followed by gas chromatography and the raw material N-methoxyoxalanine was found The methyl ester is completely consumed. After the reaction, it was confirmed by gas chromatography that the product obtained was 4-methyl-5-methoxyoxazole, and its internal standard molar yield was 86% (yield based on N-methoxyoxalanine methyl Ester, detected by internal standard method, n-octadecane is internal standard), and 13% (molar yield) of N,N-diethylformyl chloride is generated at the same time (yield is based on phosgene, external standard method).
4-甲基-5-甲氧基噁唑的制备Preparation of 4-methyl-5-methoxyoxazole
实施例4Example 4
(使用三苯基氧膦为助剂)(Use triphenyl phosphine oxide as an additive)
在反应瓶中,加入20.8g N-甲氧草酰丙氨酸甲酯(0.11mol)和42.4g三乙胺(0.42mol),0.31g三苯基氧膦(1.1mmol),用30mL二氯甲烷溶解后,0~5℃及搅拌条件下滴加双光气溶液(13.1g,0.066mol,溶解于50mL二氯 甲烷),约1小时滴加完毕,然后再加热到50℃反应1.5小时,气相色谱跟踪反应发现原料N-甲氧草酰丙氨酸甲酯完全消耗。反应结束后,通过气相色谱检测,确认所得产品为4-甲基-5-甲氧基噁唑,且其内标摩尔收率为97%(收率基于N-甲氧草酰丙氨酸甲酯,内标法检测,正十八烷为内标),同时生成2%(摩尔收率)的N,N-二乙基甲酰氯(收率基于2倍的双光气,外标法)。In the reaction flask, add 20.8g N-methoxyoxalanine methyl ester (0.11mol) and 42.4g triethylamine (0.42mol), 0.31g triphenylphosphine oxide (1.1mmol), and use 30mL dichloromethane After the methane is dissolved, add diphosgene solution (13.1g, 0.066mol, dissolved in 50mL dichloromethane) dropwise at 0~5°C and stirring. The addition is completed in about 1 hour, and then the reaction is heated to 50°C for 1.5 hours. Gas chromatography followed the reaction and found that the raw material N-methoxyoxalanine methyl ester was completely consumed. After the reaction, it was confirmed by gas chromatography that the product obtained was 4-methyl-5-methoxyoxazole, and its internal standard molar yield was 97% (yield based on N-methoxyoxalanine methyl Ester, detected by internal standard method, n-octadecane is internal standard), and 2% (molar yield) of N,N-diethylformyl chloride is generated at the same time (yield is based on 2 times of diphosgene, external standard method) .
比较例4Comparative example 4
在反应瓶中,加入20.8g N-甲氧草酰丙氨酸甲酯(0.11mol)和42.4g三乙胺(0.42mol),用30mL二氯甲烷溶解后,0~5℃及搅拌条件下滴加双光气溶液(13.1g,0.066mol,溶解于50mL二氯甲烷),约1小时滴加完毕,然后再加热到50℃反应2.5小时,气相色谱跟踪反应发现原料N-甲氧草酰丙氨酸甲酯完全消耗。反应结束后,通过气相色谱检测,确认所得产品为4-甲基-5-甲氧基噁唑,且其内标摩尔收率为88%(收率基于N-甲氧草酰丙氨酸甲酯,内标法检测,正十八烷为内标),同时生成12%(摩尔收率)的N,N-二乙基甲酰氯(收率基于2倍的双光气,外标法)。In the reaction flask, add 20.8g of N-methoxyoxalanine methyl ester (0.11mol) and 42.4g of triethylamine (0.42mol), dissolve in 30mL of dichloromethane, 0~5℃ and under stirring conditions Diphosgene solution (13.1g, 0.066mol, dissolved in 50mL of dichloromethane) was added dropwise, and the addition was completed in about 1 hour, and then heated to 50°C for 2.5 hours. The reaction was followed by gas chromatography and the raw material N-methoxyoxalyl was found Alanine methyl ester is completely consumed. After the reaction, it was confirmed by gas chromatography that the product obtained was 4-methyl-5-methoxyoxazole, and its internal standard molar yield was 88% (yield based on N-methoxyoxalanine methyl Ester, detected by internal standard method, n-octadecane as internal standard), while generating 12% (molar yield) of N,N-diethylformyl chloride (yield based on 2 times diphosgene, external standard method) .
将以上实施例和比较例汇总于下表1中。The above examples and comparative examples are summarized in Table 1 below.
表1:实施例和比较例中各原料及其用量、反应时间和产物Table 1: The raw materials and their amounts, reaction time and products in the Examples and Comparative Examples
Figure PCTCN2020115924-appb-000010
Figure PCTCN2020115924-appb-000010
上述表1可以看出,在本发明的反应体系中使用式(I)表示的三烃基氧膦、式(II)表示的磷酸三烃基酯或者式(III)表示的芳基硼酸化合物的助剂的实施例与没有使用这些助剂的比较例相比,可以缩短反应时间2小时左右,并将产物噁唑类化合物的收率提高至95%以上,同时可以减少10%以上的副产品N,N-二乙基甲酰氯。It can be seen from Table 1 above that the trihydrocarbyl phosphine oxide represented by the formula (I), the trihydrocarbyl phosphate represented by the formula (II) or the aryl boronic acid compound represented by the formula (III) are used in the reaction system of the present invention. Compared with the comparative examples that do not use these additives, the examples can shorten the reaction time by about 2 hours, increase the yield of the product oxazole compounds to more than 95%, and reduce the by-products N, N by more than 10%. -Diethylformyl chloride.

Claims (10)

  1. 一种制备噁唑类化合物的方法,其特征在于:所述方法包括,向含有选自下式(I)表示的三烃基氧膦、下式(II)表示的磷酸三烃基酯和下式(III)表示的芳基硼酸化合物中的一种或多种的助剂,下式(IV)表示的草酰化氨基酸酯化合物和有机碱的有机溶剂溶液中,添加选自光气、双光气和三光气中的一种或多种的有机溶剂溶液进行反应,得到式(V)所示的噁唑类化合物:A method for preparing oxazole compounds, characterized in that: the method comprises: adding a trihydrocarbyl phosphine oxide selected from the following formula (I), a trihydrocarbyl phosphate represented by the following formula (II), and the following formula ( III) One or more auxiliary agents in the aryl boronic acid compound represented by the following formula (IV) and the organic solvent solution of the oxalylated amino acid ester compound and organic base are added selected from phosgene and diphosgene React with one or more organic solvent solutions in triphosgene to obtain the oxazole compound represented by formula (V):
    Figure PCTCN2020115924-appb-100001
    Figure PCTCN2020115924-appb-100001
    其中,式(I)中,各R 1相同或不同,并且选自包含1~20个碳原子的烷基、包含3~20个碳原子的环烷基或者包含6~20个碳原子的取代或未取代的芳基;优选甲基、乙基、丙基、正丁基、异丁基、叔丁基、己基、环己基、辛基、正十一烷基、苯基、对甲基苯基、或对甲氧基苯基;更优选苯基、对甲基苯基、叔丁基、或环己基; Wherein, in formula (I), each R 1 is the same or different, and is selected from an alkyl group containing 1 to 20 carbon atoms, a cycloalkyl group containing 3 to 20 carbon atoms, or a substituent containing 6 to 20 carbon atoms Or unsubstituted aryl; preferably methyl, ethyl, propyl, n-butyl, isobutyl, tert-butyl, hexyl, cyclohexyl, octyl, n-undecyl, phenyl, p-toluene Group, or p-methoxyphenyl; more preferably phenyl, p-methylphenyl, t-butyl, or cyclohexyl;
    式(II)中,各R 2相同或不同,并且选自包含1~20个碳原子的烷基、包含3~20个碳原子的环烷基或者包含6~20个碳原子的取代或未取代的芳基;优选甲基、乙基、丙基、正丁基、异丁基、叔丁基、己基、环己基、辛基、正十一烷基、苯基、对甲基苯基、或对甲氧基苯基;更优选苯基、乙基、或异丙基; In formula (II), each R 2 is the same or different, and is selected from an alkyl group containing 1-20 carbon atoms, a cycloalkyl group containing 3-20 carbon atoms, or substituted or unsubstituted 6-20 carbon atoms. Substituted aryl groups; preferably methyl, ethyl, propyl, n-butyl, isobutyl, tert-butyl, hexyl, cyclohexyl, octyl, n-undecyl, phenyl, p-methylphenyl, Or p-methoxyphenyl; more preferably phenyl, ethyl, or isopropyl;
    式(III)中,各R 3相同或不同,并且选自氢、或包含1~10个碳原子的烷基;
    Figure PCTCN2020115924-appb-100002
    为包含6~20个碳原子的取代或未取代的芳基;优选苯基、对甲基苯基、对氯苯基、对甲氧基苯基、或萘基;
    In formula (III), each R 3 is the same or different, and is selected from hydrogen or an alkyl group containing 1 to 10 carbon atoms;
    Figure PCTCN2020115924-appb-100002
    Is a substituted or unsubstituted aryl group containing 6-20 carbon atoms; preferably phenyl, p-methylphenyl, p-chlorophenyl, p-methoxyphenyl, or naphthyl;
    式(IV)和(V)中,各R 4相同或不同,并且选自包含1~5个碳原子的烷基,优选甲基、乙基、正丙基、异丙基、或正丁基;R 5为H或者包含1~5个碳原子的烷基,优选甲基、乙基、正丙基、异丙基、或正丁基。 In formulas (IV) and (V), each R 4 is the same or different, and is selected from alkyl groups containing 1 to 5 carbon atoms, preferably methyl, ethyl, n-propyl, isopropyl, or n-butyl ; R 5 is H or an alkyl group containing 1 to 5 carbon atoms, preferably methyl, ethyl, n-propyl, isopropyl, or n-butyl.
  2. 根据权利要求1所述的制备噁唑类化合物的方法,其中,所述式(IV)表示的草酰化氨基酸酯化合物的质量与反应体系中的有机溶剂的总体积的比为0.05g/mL~1.0g/mL,优选0.1g/mL~0.5g/mL。The method for preparing an oxazole compound according to claim 1, wherein the ratio of the mass of the oxalylated amino acid ester compound represented by the formula (IV) to the total volume of the organic solvent in the reaction system is 0.05 g/mL ~1.0g/mL, preferably 0.1g/mL~0.5g/mL.
  3. 根据权利要求1或2所述的制备噁唑类化合物的方法,其中,所述助剂的用量为所述式(IV)表示的草酰化氨基酸酯化合物的0.01~0.2当量,优选0.05~0.1当量。The method for preparing oxazole compounds according to claim 1 or 2, wherein the amount of the auxiliary agent is 0.01 to 0.2 equivalents of the oxalylated amino acid ester compound represented by the formula (IV), preferably 0.05 to 0.1 equivalent.
  4. 根据权利要求1-3任一项所述的制备噁唑类化合物的方法,其中,所述有机碱的用量为所述光气用量的0.06~6当量,优选1~6当量;或者为双光气用量的0.12~12当量,优选2~12当量;或者为三光气用量的0.18~18当量,优选3~18当量。The method for preparing oxazole compounds according to any one of claims 1 to 3, wherein the amount of the organic base is 0.06 to 6 equivalents of the amount of phosgene, preferably 1 to 6 equivalents; or double light 0.12-12 equivalents of the amount of gas, preferably 2-12 equivalents; or 0.18-18 equivalents of the amount of triphosgene, preferably 3-18 equivalents.
  5. 根据权利要求1-4任一项所述的制备噁唑类化合物的方法,其中,所述光气的用量为所述式(IV)表示的草酰化氨基酸酯化合物的1~3当量,优选1~2当量;所述双光气的用量为所述式(IV)表示的草酰化氨基酸酯化合物的0.5~1.5当量,优选0.5~1当量;所述三光气的用量为所述式(IV)表示的草酰化氨基酸酯化合物的0.33~1当量,优选0.33~0.7当量。The method for preparing oxazole compounds according to any one of claims 1 to 4, wherein the amount of the phosgene is 1 to 3 equivalents of the oxalylated amino acid ester compound represented by the formula (IV), preferably 1 to 2 equivalents; the amount of diphosgene is 0.5 to 1.5 equivalents, preferably 0.5 to 1 equivalent of the oxalylated amino acid ester compound represented by the formula (IV); the amount of triphosgene is the formula ( IV) 0.33-1 equivalent of the oxalylated amino acid ester compound represented, preferably 0.33-0.7 equivalent.
  6. 根据权利要求1-5任一项所述的制备噁唑类化合物的方法,其中,反应温度是-10℃~180℃,优选25℃~100℃。The method for preparing oxazole compounds according to any one of claims 1-5, wherein the reaction temperature is -10°C to 180°C, preferably 25°C to 100°C.
  7. 根据权利要求1-6任一项所述的制备噁唑类化合物的方法,其中,所述式(I)表示的三烃基氧膦为三苯基氧膦、三对甲基苯基氧膦、三叔丁基氧膦、和三环己基氧膦中的一种或多种;The method for preparing oxazole compounds according to any one of claims 1 to 6, wherein the trihydrocarbyl phosphine oxide represented by the formula (I) is triphenyl phosphine oxide, tri-p-methylphenyl phosphine oxide, One or more of tri-tert-butyl phosphine oxide and tricyclohexyl phosphine oxide;
    所述式(II)表示的磷酸三烃基酯为磷酸三苯酯、磷酸三乙酯、和磷酸三异丙酯中的一种或多种;The trihydrocarbyl phosphate represented by formula (II) is one or more of triphenyl phosphate, triethyl phosphate, and triisopropyl phosphate;
    所述式(III)表示的芳基硼酸化合物为苯硼酸、萘硼酸、对甲氧基苯硼酸、和对甲基苯硼酸中的一种或多种。The arylboronic acid compound represented by the formula (III) is one or more of phenylboronic acid, naphthaleneboronic acid, p-methoxyphenylboronic acid, and p-tolueneboronic acid.
  8. 根据权利要求1-7任一项所述的制备噁唑类化合物的方法,其中,所 述式(IV)表示的草酰化氨基酸酯化合物为N-乙氧草酰丙氨酸乙酯、N-正丁氧草酰丙氨酸正丁酯、和N-甲氧草酰丙氨酸甲酯中的一种或多种。The method for preparing oxazole compounds according to any one of claims 1-7, wherein the oxalylated amino acid ester compound represented by formula (IV) is N-ethoxyoxalanine ethyl ester, N -One or more of n-butoxy oxalyl alanine n-butyl ester and N-methoxy oxalyl alanine methyl ester.
  9. 根据权利要求1-8任一项所述的制备噁唑类化合物的方法,其中,所述有机碱为吡啶、二异丙基乙基胺、二甲胺、三乙胺、4-N,N-二甲氨基吡啶、和4-甲基咪唑中的一种或多种,优选三乙胺。The method for preparing oxazole compounds according to any one of claims 1-8, wherein the organic base is pyridine, diisopropylethylamine, dimethylamine, triethylamine, 4-N,N -One or more of dimethylaminopyridine and 4-methylimidazole, preferably triethylamine.
  10. 根据权利要求1-9任一项所述的制备噁唑类化合物的方法,其中,所述有机溶剂为二氯甲烷、三氯甲烷、1,2-二氯乙烷、1,1,2-三氯乙烷、氯苯、甲苯、二甲苯、N,N-二甲基甲酰胺、甲基叔丁基醚、异丙醚、环戊基甲基醚、乙二醇二甲醚、四氢呋喃、2-甲基四氢呋喃、环己烷、正己烷、和石油醚中的一种或多种;优选二氯甲烷、三氯甲烷、1,1,2-三氯乙烷、氯苯、甲苯、二甲苯、N,N-二甲基甲酰胺、环己烷、正己烷、和石油醚中的一种或多种。The method for preparing oxazole compounds according to any one of claims 1-9, wherein the organic solvent is dichloromethane, chloroform, 1,2-dichloroethane, 1,1,2- Trichloroethane, chlorobenzene, toluene, xylene, N,N-dimethylformamide, methyl tert-butyl ether, isopropyl ether, cyclopentyl methyl ether, ethylene glycol dimethyl ether, tetrahydrofuran, One or more of 2-methyltetrahydrofuran, cyclohexane, n-hexane, and petroleum ether; preferably dichloromethane, trichloromethane, 1,1,2-trichloroethane, chlorobenzene, toluene, dichloromethane, One or more of toluene, N,N-dimethylformamide, cyclohexane, n-hexane, and petroleum ether.
PCT/CN2020/115924 2020-01-19 2020-09-17 Method for preparing oxazole compound WO2021143181A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202010058825.4 2020-01-19
CN202010058825.4A CN111153869B (en) 2020-01-19 2020-01-19 Method for preparing oxazole compound

Publications (1)

Publication Number Publication Date
WO2021143181A1 true WO2021143181A1 (en) 2021-07-22

Family

ID=70564169

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2020/115924 WO2021143181A1 (en) 2020-01-19 2020-09-17 Method for preparing oxazole compound

Country Status (2)

Country Link
CN (1) CN111153869B (en)
WO (1) WO2021143181A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111153869B (en) * 2020-01-19 2021-06-01 浙江新和成股份有限公司 Method for preparing oxazole compound
CN112174907B (en) * 2020-10-12 2022-08-12 新发药业有限公司 Environment-friendly preparation method of substituted oxazole compound
CN113336717B (en) * 2021-06-01 2024-04-05 江西天新药业股份有限公司 Process for preparing oxazolecarboxylic acid esters

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103435568A (en) * 2013-08-30 2013-12-11 大丰海嘉诺药业有限公司 Preparation method of 4-methyl-5-ethoxy oxazole acid ethyl
CN105985297A (en) * 2015-01-30 2016-10-05 湖北得正医药科技有限公司 Synthesis technology of vitamin B6 intermediate 4-methyl-5-ethyoxyl-2-oxazole acid ethyl
CN110240573A (en) * 2019-07-04 2019-09-17 山东新和成精化科技有限公司 A method of preparing polysubstituted evil azole compounds
CN111153869A (en) * 2020-01-19 2020-05-15 浙江新和成股份有限公司 Method for preparing oxazole compound
CN111793038A (en) * 2019-04-08 2020-10-20 新发药业有限公司 Environment-friendly preparation method of substituted oxazole compound

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1645987A1 (en) * 1966-08-08 1971-01-21 Ajinomoto Kk Oxalzole derivatives and processes for their preparation
CN1003515B (en) * 1986-07-07 1989-03-08 国家医药管理局上海医药工业研究院 Synthetizing technology of vit. b6 intermediate 4-methyl-5-alkoxy-oxazole
US6160117A (en) * 1997-11-06 2000-12-12 Zeneca Limited Chemical process
CN102321043A (en) * 2011-07-12 2012-01-18 湖北惠生药业有限公司 Preparation method for 4-methyl-5-ethyoxyl-oxazole
CN107011252B (en) * 2017-06-09 2018-06-08 浙江工业大学 The method for drawing azole intermediate and drug is prepared using the green technology for substituting the poisonous and harmful substances such as phosgene, thionyl chloride

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103435568A (en) * 2013-08-30 2013-12-11 大丰海嘉诺药业有限公司 Preparation method of 4-methyl-5-ethoxy oxazole acid ethyl
CN105985297A (en) * 2015-01-30 2016-10-05 湖北得正医药科技有限公司 Synthesis technology of vitamin B6 intermediate 4-methyl-5-ethyoxyl-2-oxazole acid ethyl
CN111793038A (en) * 2019-04-08 2020-10-20 新发药业有限公司 Environment-friendly preparation method of substituted oxazole compound
CN110240573A (en) * 2019-07-04 2019-09-17 山东新和成精化科技有限公司 A method of preparing polysubstituted evil azole compounds
CN111153869A (en) * 2020-01-19 2020-05-15 浙江新和成股份有限公司 Method for preparing oxazole compound

Also Published As

Publication number Publication date
CN111153869A (en) 2020-05-15
CN111153869B (en) 2021-06-01

Similar Documents

Publication Publication Date Title
WO2021143181A1 (en) Method for preparing oxazole compound
JP4138662B2 (en) Process for preparing alkyl diaryl borinates and complexed diaryl boronic acids.
EP3305769B1 (en) Method for preparation of (7-phenoxy-4-hydroxy-1-methyl-isoquinoline-3-carbonyl)-glycine (roxedustat) and its intermediates based on simultaneous opening of oxazolic ring, fission of ether and creation of imine
CN103570696B (en) A kind of preparation method of Axitinib intermediate and preparing the application in Axitinib
CN104530040A (en) Novel method for synthesizing 1,2,3-thiadiazole-5-formamidine compound
WO2011035532A1 (en) Preparation method of aromatic borate ester compound
US9000205B2 (en) Process for the preparation of 2-cyanophenylboronic acid and esters thereof
CN111072697B (en) Preparation method of 4-phenoxyphenylboronic acid
CN115197261B (en) Synthesis method of oxadiazine boron derivative
CN112778347B (en) Synthetic method of boron nitrogen benzocarbazole derivative
CN114702425A (en) Preparation method of (S) -2-amino- (S) -3- [ pyrrolidone-2' ] alanine derivative and intermediate
CN114478424A (en) Preparation method of azlactone derivative with beta-substituted cycloalkenyl
CN111499622B (en) Preparation method of medicine for treating bile duct cancer
CN109574830B (en) Rosuvastatin calcium intermediate, and preparation method and application thereof
CN107382899B (en) Polysubstituted 2-hydroxy-1, 4-benzoxazine derivative
CN104478799A (en) Preparation method of 1,4-diallyl isoquinoline
KR101113791B1 (en) Novel potassium azidoaryltrifluoroborate derivatives and method for producing the same
CN110577520B (en) Preparation method of 6-nitro-4-substituted amino quinazoline derivative
JPS5927343B2 (en) Synthesis method of 3-aminoisoxazoles
TWI685485B (en) Processes to produce acalabrutinib
JP4380160B2 (en) Process for producing 7-quinolinyl-3,5-dihydroxyhept-6-enoic acid ester
CN105111125B (en) A kind of synthetic method of pharmaceutical intermediate condensed hetero ring ketone compounds
JP4663105B2 (en) Method for producing 2-sulfonyl-4-oxypyridine derivative
Levin et al. Pentafluorophenylation of-aminoacrylates
JPH0240672B2 (en) 55FUENIRUAMINOO11FUENIRUU1HHPIRAZORO * 3 * 44B * PIRAJINJUDOTAI

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20913550

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 20913550

Country of ref document: EP

Kind code of ref document: A1